TomoTherapy Incorporated develops, markets and sells advanced radiation therapy solutions that can be used to treat a wide variety of cancers, from the most common to the most complex. The ring gantry-based TomoTherapy ® platform combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. TomoTherapy's suite of solutions include its flagship Hi·Art ® treatment system, which has been used to deliver more than three million CT-guided, helical intensity-modulated radiation therapy (IMRT) treatment fractions; the TomoHD ™ treatment system, designed to enable cancer centers to treat a broader patient population with a single device; and the TomoMobile ™ relocatable radiation therapy solution, designed to improve access and availability of state-of-the-art cancer care. TomoTherapy's stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.
More |  | |
|
Active Webcasts |
| Date | Title | | | 08/24/10 | TomoTherapy Enables General Hospital of Guangzhou Military Command of
PLA to Provide Advanced Care to Patients With Head and Neck Cancers| Installation of TomoTherapy(R) Treatment System Is First in Southern China
MADISON, WI, Aug 24, 2010 (MARKETWIRE via COMTEX) --TomoTherapy Incorporated (NASDAQ: TOMO), maker of advanced,
integrated radiation therapy solutions for cancer care, announced
today that General Hospital of Guangzhou Military Command of PLA has
purchased the first TomoTherapy(R) radiation therapy system to be
installed in Southern China. The TomoTherapy treatment system will
enable the hospital to provide advan... |
|  | | 08/19/10 | TomoTherapy Co-Founder and Chairman Rock Mackie to Be Honored at
ESTRO 29 in Barcelona, September 12-16| Mackie to Address Role of Imaging in the Future of Cancer Care in September 13 Lecture
MADISON, WI, Aug 19, 2010 (MARKETWIRE via COMTEX) --TomoTherapy Incorporated (NASDAQ: TOMO), maker of advanced radiation
therapy solutions for cancer care, announced today that its
Co-Founder and Chairman of the Board, Thomas Rockwell "Rock" Mackie,
Ph.D., will be awarded honorary membership into the European Society
for Therapeutic Radiology and Oncology (ESTRO) at ESTRO 29, the
organization's bi-ann... |
| | | 07/29/10 | TomoTherapy Announces Second Quarter Financial Results| Reports $47.6 Million of Revenue; $42.5 Million of Equipment Orders
MADISON, WI, Jul 29, 2010 (MARKETWIRE via COMTEX) --TomoTherapy Incorporated (NASDAQ: TOMO), producer of the Hi*Art(R)
treatment system and other products for advanced radiation therapy,
today released financial results for the second quarter ended June
30, 2010.
Second Quarter Results
Second quarter 2010 revenue was $47.6 million, an increase of 16%
from $41.1 million in the second quarter of 2009. Revenue from... |
| | | 07/16/10 | James Cook University Hospital Introduces Advanced TomoTherapy(R)
Radiation Therapy Treatments| MADISON, WI, Jul 16, 2010 (MARKETWIRE via COMTEX) --TomoTherapy Incorporated (NASDAQ: TOMO) maker of advanced,
integrated radiation therapy solutions for cancer care, today
announced that James Cook University Hospital (JCUH) in
Middlesbrough, England began treating cancer patients with the
TomoTherapy(R) Hi-Art(R) treatment system last month. The TomoTherapy
treatment system, which enables delivery of state-of-the-art CT
image-guided intensity modulated radiotherapy (IG-IMRT), reinforces
... |
| |
|
|
| There are currently no events scheduled. |
| There are currently no items available. |
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. |
|
